← The Wire
GYRENasdaq
GYRE THERAPEUTICS, INC.
Pharmaceutical Preparations · DE · CIK 1124105
Develops and commercializes small-molecule therapies for organ fibrosis and inflammatory diseases
red 8-K · 90d
$575M
Market cap
$6.45
Last close
+2.5%
1D
+5.2%
5D
80K
Volume
Price · last 39 sessions-18.6%
May 4L $5.56 · H $8.04Jun 29
386
Total filings
Jun 16, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AMay 4, 2026DEFA14ADEFA14AApr 27, 2026DEFA14ADEFA14AApr 21, 2025DEFA14ADEFA14AApr 29, 2024DEFA14ADEFA14AJun 20, 2023DEFA14ADEFA14AMay 5, 2023DEFA14ADEFA14AApr 7, 2023DEFA14ADEFA14AMar 30, 2023DEFA14A8-KMar 21, 2023DEFA14ADEFA14AMar 2, 2023DEFA14ADEFA 14AAug 10, 2022DEFA14ADEFA14AAug 4, 2022DEFA14AFORM DEFA14AAug 3, 2022DEFA14ADEFA14AAug 1, 2022DEFA14ADEFA14AAug 1, 2022DEFA14ADEFA14AJul 29, 2022DEFA14AFORM DEFA14AJul 19, 2022DEFA14ADEFA14AJul 6, 2022DEFA14ADEFA14AJun 29, 2022DEFA14ADEFA14AJun 28, 2022DEFA14ADEFA14AJun 9, 2022DEFA14ADEFA14AMay 20, 2021DEFA14ADEFA14AApr 27, 2021DEFA14ADEFA14AMay 1, 2020DEFA14ADEFA14AMay 2, 2019DEFA14AADDITIONAL MATERIALSApr 18, 2014
Similar companies
Comparable business profile · signals at a glance